Company news

Humacyte, Inc. news in 2021

Humacyte, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Humacyte Announces the Appointments of Three Surgical and Cardiovascular Opinion Leaders to Advisory Roles

December 30, 2021

Humacyte Announces Publication Highlighting the First Use of the Human Acellular Vessel (HAV™) as Arterial Bypass Conduit for Replacement of Infected Prosthetic Graft

December 14, 2021

Humacyte Presents Preclinical Results of Small-Diameter HAV™ for Use as a BTT Shunt in Pediatric Heart Disease at American Heart Association’s Scientific Sessions 2021

November 15, 2021

Humacyte Presents New 12-Month Data from HAVs™ Produced Using Commercial-Scale Manufacturing System

November 14, 2021

Humacyte Reports Third Quarter 2021 Financial Results and Provides Business Highlights

November 11, 2021

Humacyte Announces Issuance of Three Additional U.S. Patents Covering its Proprietary Universally Implantable Bioengineered Human Tissue Platform

September 19, 2021

Decks in 2021